Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.3172 | 0.3172 |
Echinococcus granulosus | roundabout 2 | 0.0016 | 0.3172 | 1 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0018 | 0.4521 | 1 |
Schistosoma mansoni | nephrin | 0.0016 | 0.3172 | 1 |
Echinococcus granulosus | twitchin | 0.0016 | 0.3172 | 1 |
Echinococcus granulosus | neuroglian | 0.0016 | 0.3172 | 1 |
Echinococcus multilocularis | roundabout 2 | 0.0016 | 0.3172 | 1 |
Echinococcus multilocularis | neuroglian | 0.0016 | 0.3172 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 1.8 uM | Antitrypanosomal activity against blood stage of Trypanosoma brucei rhodesiense STIB 900 (S704) Tanzania after 70 hrs by Alamar Blue assay | ChEMBL. | 23648975 |
GI50 (ADMET) | > 100 uM | Cytotoxicity against human THP1 macrophages after 48 hrs by Alamar Blue assay | ChEMBL. | 23648975 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.